News
03-14-2010, 01:40 PM
Drugmaker Pfizer says that the drug Sutent did not meet expectations in two late-stage trials for advanced breast cancer.
More... (http://www.healthcentral.com/breast-cancer/news-481348-98.html)
More... (http://www.healthcentral.com/breast-cancer/news-481348-98.html)